200 related articles for article (PubMed ID: 22198237)
1. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
Egleton RD; Brown KC; Dasgupta P
Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
[TBL] [Abstract][Full Text] [Related]
3. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells.
Wong HP; Yu L; Lam EK; Tai EK; Wu WK; Cho CH
Toxicol Appl Pharmacol; 2007 Jun; 221(3):261-7. PubMed ID: 17498763
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
5. The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.
Dom AM; Buckley AW; Brown KC; Egleton RD; Marcelo AJ; Proper NA; Weller DE; Shah YH; Lau JK; Dasgupta P
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4428-38. PubMed ID: 20554619
[TBL] [Abstract][Full Text] [Related]
6. GW1929 inhibits α7 nAChR expression through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR: The role of Egr-1.
Hahn SS; Tang Q; Zheng F; Zhao S; Wu J
Cell Signal; 2014 Apr; 26(4):730-9. PubMed ID: 24412748
[TBL] [Abstract][Full Text] [Related]
7. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
8. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration.
Ng MK; Wu J; Chang E; Wang BY; Katzenberg-Clark R; Ishii-Watabe A; Cooke JP
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):106-12. PubMed ID: 17082486
[TBL] [Abstract][Full Text] [Related]
9. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
10. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of alpha7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells.
Hsu SH; Tsou TC; Chiu SJ; Chao JI
Toxicol Lett; 2005 Oct; 159(1):47-59. PubMed ID: 15961264
[TBL] [Abstract][Full Text] [Related]
12. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
13. Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization.
Li XW; Wang H
Life Sci; 2006 Mar; 78(16):1863-70. PubMed ID: 16280133
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
16. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes.
Arredondo J; Chernyavsky AI; Jolkovsky DL; Pinkerton KE; Grando SA
FASEB J; 2006 Oct; 20(12):2093-101. PubMed ID: 17012261
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
19. SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo.
Chao WR; Amin K; Shi Y; Hobbs P; Tanabe M; Tanga M; Jong L; Collins N; Peters R; Laderoute K; Dinh D; Yean D; Hou C; Sato B; Alt C; Sambucetti L
Angiogenesis; 2011 Mar; 14(1):1-16. PubMed ID: 21104121
[TBL] [Abstract][Full Text] [Related]
20. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.
Heeschen C; Weis M; Aicher A; Dimmeler S; Cooke JP
J Clin Invest; 2002 Aug; 110(4):527-36. PubMed ID: 12189247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
